October 14, 2014

The Pharmaceutical Research and Manufacturers of America on Tuesday launched AccessBetterCoverage.org.

 

October 10, 2014

The Drug Enforcement Administration’s final rule moving hydrocodone combination products from Schedule III to the more-restrictive Schedule II officially went into effect on Monday. 

October 9, 2014

The Food and Drug Administration earlier this month issued draft guidance with several recommendations for manufacturers of acetaminophen products. 

October 8, 2014

"What happens when student pharmacists discover that their professional path may prove equal parts public health and public policy?"

October 7, 2014

Sandoz announced the launch of its dexmedetomidine hydrochloride injection, a generic version of Precedex from Hospira. 

October 6, 2014

Seven influenza vaccine manufacturers projected that as many as 151 million to 159 million doses of influenza vaccine will be available for use in the United States.

October 6, 2014

Healthcare Distribution Management Association released a statement in support of the FDA’s “Know Your Source” campaign.

October 6, 2014

Mylan announced the launch of its lamivudine and zidovudine tablets USP, in 150-mg dosage strength.

October 6, 2014

Sam’s Club is making vaccinations as affordable as possible by matching the price of any competitor with their low price promise.

October 3, 2014

In celebration of all that they do, October is designated as American Pharmacists Month. Drug Store News wants to hear from you! Have you had a pharmacist that went above and beyond to help?

October 2, 2014

Walgreens on Thursday announced a first-of-its-kind partnership with the Department of Veterans Affairs to improve care coordination and integrate immunization records for more than 8.5 million VA-enrolled patients.

October 1, 2014

October is recognized as American Pharmacists Month and the American Pharmacists Association wants to send a clear message: “Know Your Pharmacist—Know Your Medicine.”

September 30, 2014

Camber Pharmaceuticals, a generic drugs supplier, presented Target with its "Outstanding Partnership" award for 2014. 

September 30, 2014

Wholesaler H.D. Smith last week promoted Dmitrey Kuznetsov to VP generic pharmaceuticals. 

September 30, 2014

Par Pharmaceutical on Tuesday announced that it has started shipping amlodipine and valsartan tablets in all four dosage strengths.

September 29, 2014

According to a report released Monday by Thomson Reuters BioWorld, currently there are 700 follow-on biologics therapies moving through pipelines with many already approved.

September 26, 2014

Actavis on Friday confirmed that it has filed an abbreviated new drug application with the Food and Drug Administration to market buprenorphine transdermal system, a generic version of Butrans from Purdue Pharma. 

September 26, 2014

Camber Pharmaceuticals announced the launch of raloxifene hydrochloride, USP tablets in 60-mg dosage strengths.

September 26, 2014

Drug Store News director of continuing education and clinical content Suzanne Feeney, PharmD, will take over the Drug Store News twitter handle @drugstorenews, as part of the global #Pharmacist tweet-a-thon on Thursday, Oct. 2.

September 24, 2014

Dr. Reddy's Labs on Wednesday announced the launch of levalbuterol inhalation solution, USP in 0.31-mg, 0.63-mg and 1.25-mg unit-dose vials.

September 24, 2014

In honor of the 30th anniversary of the Drug Price Competition and Patent Term Restoration Act — more commonly known as the Hatch Waxman Act — which enabled manufacturers to bring generic versions of pharmaceuticals to market more easily, GPHA president Ralph Neas issued a statement.

September 24, 2014

Want satisfied pharmacy customers? Ensure that they have direct interaction and collaboration with pharmacists and implement an in-store clinic or wellness center. 

 

September 23, 2014

A bill has been introduced that lawmakers say would “close federal loopholes” and increase consumer access to generic drugs while boosting market competition.

September 23, 2014

Sandoz announced the launch of Kerydin (tavaborole) topical solution, 5% in the United States. Kerydin is the first oxaborole antifungal for the topical treatment of onychomycosis of the toenails due to trichophyton rubrum or trichophyton mentagrophytes, the company stated.